Health comorbidities and cognition in 1948 patients with idiopathic Parkinson's disease

被引:30
|
作者
Jones, J. D. [1 ,3 ]
Malaty, I. [2 ,3 ]
Price, C. C. [1 ,3 ]
Okun, M. S. [2 ,3 ]
Bowers, D. [1 ,2 ,3 ]
机构
[1] Univ Florida, McKnight Brain Inst, Dept Clin & Hlth Psychol, Gainesville, FL 32601 USA
[2] Univ Florida, McKnight Brain Inst, Dept Neurol, Gainesville, FL 32601 USA
[3] Univ Florida, McKnight Brain Inst, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32601 USA
关键词
Parkinson's disease/Parkinsonism; Neuropsychology; Cardiovascular; Comorbidities; Prevalence; WHITE-MATTER HYPERINTENSITIES; RISK-FACTORS; DEMENTIA; IMPAIRMENT; BRAIN; AGE; HYPERTENSION; INCIDENT; IMPACT;
D O I
10.1016/j.parkreldis.2012.06.004
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Health comorbidities, particularly cardiovascular factors, are well known to pose risks for cognitive decline in older adults. This study examined the prevalence and contribution of comorbidities on cognitive performance in a large cohort of Parkinson patients. Methods: Data on 1948 PD patients were obtained from the National Parkinson Foundation Quality Improvement Initiative (NPF-QII) registry, a multi-site initiative from NPF Centers of Excellence. Available comorbidity data included six common conditions (heart/circulation problems, diabetes, arthritis, cancer, respiratory disease, and other neurologic disease) that were clinician-rated for presence and severity. Available cognitive measures included semantic fluency and a 5-word recall memory task. The unique effects of comorbidities on cognition were analyzed (multiple hierarchical regression) controlling for demographic, PD disease severity (duration, Hoehn-Yahr), and medication status. Results: The two most reported comorbidities were arthritis (46.6%) and heart/circulation problems (36.3%), with diabetes affecting 9% of the sample. Severity of heart/circulation problems independently contributed to worse delayed recall performance (p = 0.03). A trend emerged for more severe diabetes as contributing to worse semantic fluency scores (p = 0.06). Conclusions: This study with a large cohort of PD patients provides evidence for a small detrimental influence of specific health comorbidities, particularly heart/circulatory and diabetes, on general measures of cognition. This effect is present, above and beyond the influences of basic demographic information (age), duration and staging of PD, and medication status. Future studies involving more refined cognitive indices and direct assessment of comorbidities are warranted. (c) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1073 / 1078
页数:6
相关论文
共 50 条
  • [21] Impact of APOE Genotype on Cognition in Idiopathic and Genetic Forms of Parkinson's Disease
    Koros, Christos
    Brockmann, Kathrin
    Simitsi, Athina-Maria
    Bougea, Anastasia
    Liu, Hui
    Hauser, Ann-Kathrin
    Schulte, Claudia
    Lerche, Stefanie
    Pachi, Ioanna
    Papagiannakis, Nikolaos
    Antonelou, Roubina
    Zahou, Athina
    Wurster, Isabel
    Efthymiopoulou, Efthymia
    Beratis, Ion
    Maniati, Matina
    Moraitou, Marina
    Michelakakis, Helen
    Paraskevas, Georgios
    Papageorgiou, Sokratis G.
    Potagas, Constantin
    Papadimitriou, Dimitra
    Bozi, Maria
    Stamelou, Maria
    Gasser, Thomas
    Stefanis, Leonidas
    MOVEMENT DISORDERS, 2023, 38 (05) : 907 - 909
  • [22] Impact of ApoE genotype on cognition in idiopathic and genetic forms of Parkinson's disease
    Koros, C.
    Brockmann, K.
    Simitsi, A. M.
    Bougea, A.
    Liu, H.
    Hauser, A. K.
    Schulte, C.
    Pachi, I.
    Papagiannakis, N.
    Zahou, A.
    Wurster, I.
    Efthymiopoulou, E.
    Beratis, I.
    Antonelou, R.
    Maniati, M.
    Moraitou, M.
    Michelakakis, H.
    Paraskevas, G.
    Papageorgiou, S.
    Potagas, C.
    Papadimitriou, D.
    Bozi, M.
    Stamelou, M.
    Gasser, T.
    Stefanis, L.
    MOVEMENT DISORDERS, 2022, 37 : S540 - S540
  • [23] Cognition and Parkinson's disease
    Garrett, MC
    Fonseca, MR
    Rosas, MJ
    Simoes, F
    Vieira, S
    MOVEMENT DISORDERS, 2002, 17 : S128 - S128
  • [24] Cognition in Parkinson's Disease
    O'Callaghan, Claire
    Lewis, Simon J. G.
    NONMOTOR PARKINSON'S: THE HIDDEN FACE: THE MANY HIDDEN FACES, 2017, 133 : 557 - 583
  • [25] Cognition in Parkinson's disease
    Basic, J
    Katic, S
    Vranic, A
    Zarevski, P
    Babic, T
    Mahovic-Lakusic, D
    CROATIAN MEDICAL JOURNAL, 2004, 45 (04) : 451 - 456
  • [26] Patients' experiences of Parkinson's disease: a qualitative study in glucocerebrosidase and idiopathic Parkinson's disease
    Bonner, N.
    Bozzi, S.
    Morgan, L.
    Mason, B.
    Peterschmitt, M. J.
    Fischer, T. Z.
    Arbuckle, R.
    Reaney, M.
    JOURNAL OF PATIENT-REPORTED OUTCOMES, 2020, 4 (01)
  • [27] Patients’ experiences of Parkinson’s disease: a qualitative study in glucocerebrosidase and idiopathic Parkinson’s disease
    N. Bonner
    S. Bozzi
    L. Morgan
    B. Mason
    M. J. Peterschmitt
    T. Z. Fischer
    R. Arbuckle
    M. Reaney
    Journal of Patient-Reported Outcomes, 4
  • [28] Genetic comorbidities in Parkinson's disease
    Nalls, Mike A.
    Saad, Mohamad
    Noyce, Alastair J.
    Keller, Margaux F.
    Schrag, Anette
    Bestwick, Jonathan P.
    Traynor, Bryan J.
    Gibbs, J. Raphael
    Hernandez, Dena G.
    Cookson, Mark R.
    Morris, Huw R.
    Williams, Nigel
    Gasser, Thomas
    Heutink, Peter
    Wood, Nick
    Hardy, John
    Martinez, Maria
    Singleton, Andrew B.
    HUMAN MOLECULAR GENETICS, 2014, 23 (03) : 831 - 841
  • [29] Emotion recognition in patients with idiopathic Parkinson's disease
    Yip, JTH
    Lee, TMC
    Ho, SL
    Tsang, KL
    Li, LSW
    MOVEMENT DISORDERS, 2003, 18 (10) : 1115 - 1122
  • [30] Ocular microtremor in patients with idiopathic Parkinson's disease
    Bolger, C
    Bojanic, S
    Sheahan, NF
    Coakley, D
    Malone, JF
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1999, 66 (04): : 528 - 531